biotech · Chronic Hepatitis B · Chronic Hepatitis B Infection · ALGS
Aligos Therapeutics
Aligos Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
1 Corporate Dr, South San Francisco, California 94080, US HQ
2018 Founded
98 Employees
Public company Type
ALGS · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1 Corporate Dr, South San Francisco, California 94080, US
- Founded
- 2018
- Employees
- 98
- Programs
- 14
- Drugs
- 10
- Patents
- 32
Aligos Therapeutics projects
0 ClinicalTrials.gov programs sponsored by Aligos Therapeutics.
Aligos Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Aligos Therapeutics have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.